Log in to save to my catalogue

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growt...

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growt...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_07b7db0601e64926bfae9d5eb7556d69

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation

About this item

Full title

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation

Publisher

London, England: SAGE Publications

Journal title

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920946156-1758835920946156

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Background and aims:
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) are effective against classical EGFR mutations in lung cancer. However, their effectiveness and the prognosis of lung cancer patients with complex EGFR mutations are not well delineated. Therefore, we aimed to investigate the treatment effectiveness of d...

Alternative Titles

Full title

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_07b7db0601e64926bfae9d5eb7556d69

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_07b7db0601e64926bfae9d5eb7556d69

Other Identifiers

ISSN

1758-8359,1758-8340

E-ISSN

1758-8359

DOI

10.1177/1758835920946156

How to access this item